There are large variations in the incidence, registration methods and reported causes of sudden cardiac arrest/sudden cardiac death (SCA/SCD) in competitive and recreational athletes. A crucial question is to which degree these variations are genuine or partly due to methodological incongruities. This paper discusses the uncertainties about available data and provides comprehensive suggestions for standard definitions and a guide for uniform registration parameters of SCA/ SCD. The parameters include a definition of what constitutes an 'athlete', incidence calculations, enrolment of cases, the importance of gender, ethnicity and age of the athlete, as well as the type and level of sporting activity. A precise instruction for autopsy practice in the case of a SCD of athletes is given, including the role of molecular samples and evaluation of possible doping. Rational decisions about cardiac preparticipation screening and cardiac safety at sport facilities requires increased data quality concerning incidence, aetiology and management of SCA/SCD in sports. Uniform standard registration of SCA/SCD in athletes and leisure sportsmen would be a first step towards this goal.
Introduction
In recent times, sudden cardiac arrest/sudden cardiac death (SCA/SCD), particularly among high profile athletes, has gained huge attention. Such catastrophes have generated considerable scientific interest and triggered debates relating to controversial issues such as the magnitude and the actual causes of such events. At present, however, despite the impressive number of reports of SCA/SCD in athletes, our understanding of the precise incidence, demographics, causes and circumstances surrounding the issue remains limited. This is due to methodological inadequacies of the observational reports, which include different inclusion criteria, diverse definitions and characterization of the athletic population and non-uniform methodology in autopsy studies of competitive and recreational athletes. So far, most of the discrepancies regarding the athlete's SCA/ SCD are related to data collection, which is derived from either prospective 1 or retrospective registries, [2] [3] [4] voluntary reporting 5 or from media reports. 6 The absence of a uniform registration method means that it is impossible to compare different data sets; therefore, high quality meta-analyses are largely unachievable at the present time. Most of the reliable information relating to the incidence and causes of SCD in young athletes is derived from the Veneto region of Italy, which maintains a prospective pathology registry on SCD. However, it is difficult to extrapolate these results to all countries, which vary with respect to the ethnicity of sports participants, the nature of sporting disciplines practised, the emergency response plans in the athletic fields and the methods for performing autopsies.
Aim of paper
The aim of this paper is to provide a template for a uniform registration and autopsy procedure of SCA/SCD in competitive and recreational athletes which could be applied internationally and is based on standard definitions. The intention is to improve our understanding of SCA in athletes by supporting the implementation of a uniform method of registration of SCA/SCDs, of the autopsy procedures, of the emergency response interventions as well as outcomes, 7, 8 which could aid persons, institutions, organizations, countries or larger regions in developing strategies for preventing such tragedies.
Definitions

SCA in sport
In the present manuscript, we focus on SCA/SCD occurring during sport or in close conjunction with sporting activity. For scientific purposes, it would be useful to clearly define the term 'sudden', since this will influence the incidence rate and have an impact on the epidemiological data. For example, the proportion of all deaths defined as SCD is 13% when a definition of 1 h from onset of symptoms is used, 9 whereas the proportion of SCD rises to 19% when a 24-h time-frame is used. 10 The issue is even more complicated, however, since there are reports of malaise or SCA during sports, with death occurring several days afterwards. 4 Suggestion: For the purpose of the present paper, we rely on the definition of SCA/SCD occurring during or within a short period in relation to participation in sport. We suggest to include in the registry detailed information relating to the time interval in hours between eventual symptoms and SCA/SCD and the sporting activity and SCA/SCD; categorizing the event as occurring during or within 1-24 h post-exercise.
Competitive and recreational athletes
For the purpose of this document, 'competitive athletes' are defined as individuals who are engaged in exercise training on a regular basis and participate in official sports competition. Usually, they exercise >10 h per week. A subgroup is the 'elite athletes'. The target of the competitive athlete is to continuously improve their performance and thereby achieve the best possible results in competitions. Official sports competitions (local, regional, national or international) are defined as organized team or individual sports events that place a high premium on athletic excellence and achievement and are organized by a recognized athletic association.
In contrast, 'recreational athletes' are defined as individuals engaged in recreational or leisure-time sports activities, on either a regular basis or intermittently. Usually, they exercise <10 h per week. Recreational sports do not necessarily require systematic training or the pursuit of excellence, nor do they convey the same pressure to prevail against others.
Suggestion: 'Athletes' should be defined according to the type, frequency, duration and intensity of sport participation and categorized into 'competitive' or' recreational'.
Incidence of SCA/SCD in sport
Methodical differences in characterizing the sporting population are likely to contribute to the large variations in the reported incidence rate of SCA/SCD in sport in the literature, although a generally accepted value is 1-3:100,000. [11] [12] [13] In selected populations, such as military recruits 14 and in subpopulations of elite athletes (i.e. African-American professional athletes), the incidence of SCA/SCD has been reported to be substantially higher. The methodological limitations and inadequacies of current studies are highlighted by two investigations examining the same population of Minnesota high school athletes, but yielding widely different estimate. 15, 16 Additionally, the large variability of the prevalence of SCA/SCD may in part reflect the role of several factors that influence SCA/SCD such as the type and level of sports activity, the personal characteristics of the athlete including the age, gender and ethnicity), climate, as well as behavioural issues (including drug abuse), regardless of the existence of an underlying pathologic condition.
Suggestion: To include in the registration form factors that may predispose for SCA/SCD, such as the type and level of sports, age, gender, ethnicity, climate and athlete's specific behaviour, which may improve our understanding of the event.
Proposed elements of the registry Comprehensive enrolment of cases
The registry must have a system in place for collecting all cases at regional and national level. Often the real number of deaths (the numerator) is not consecutively and systematically reported. 5 Harmon et al. and Holst et al. showed that a larger part of the SCA in sports is not captured by media and, therefore, would not have been identified in a media-based registry. 17, 18 Steinvil et al. 6 reported an overall very low prevalence of sudden deaths in Israeli athletes based on media reports from two newspapers, raising the suspicion that many cases were missed. 19 Another source of error is that many cases cannot be classified accurately due to missing records, lack of autopsy or non-specific descriptions of pathology reports. In one retrospective registry-based study, Solberg et al. were unable to classify 17% of potential cases. 4 The strategy to ensure comprehensive case enrolment is likely to vary between different countries. One proposal would be to establish a mandatory emergency ambulance registry which is able to capture most cases of SCA/SCD. 20 Another source of data would be the reporting of all SCD cases in sports by pathology centres, which may compensate for cases where an ambulance service was not involved. To complete case enrolment, researchers should also search other relevant national sources like, for example, death registries, when available. However, the quality of the data in death registries ultimately relies on the standard of pathology and/or clinical assessment by the doctor providing the final diagnosis.
Suggestion: To capture all consecutive cases of SCA/ SCDs in the registration form by specifying the source of this information (ambulance, autopsy, or other source). It is of great relevance not to miss the survivors (successfully resuscitated SCA).
Demographics
The athlete's age, gender, ethnicity, sporting discipline and intensity of exercise may influence the incidence of SCA/SCD during sports.
Age. The incidence rate of SCD in sports is 4-5 times higher in older age groups (>35 years, e.g. master athletes) compared with athletes of a younger age ( 35 years). 12, 21, 22 These differences reflect a higher burden of underlying cardiovascular diseases (mostly, ischaemic heart disease) consistent with increasing age. Incidence numbers in the older athletes range from 1:1500 to 1:50,000. 20, [23] [24] [25] The French study on sports-related SCD in the general population shows a clear preponderance of older athletes. 26 Gender. There has traditionally been a very strong male predisposition to SCA/SCD with ratios of 10:1 amongst competitive athletes 5, 26 and up to 20:1 in the general exercising population, 12, 26 which cannot be explained uniquely by differences in gender participation rates. One large study of US collegiate athletes showed a lower male:female ratio in cases of SCD (2,3:1). 17 Ethnicity. Athletes of black ethnicity appear to have a higher incidence of SCA/SCD compared with Caucasian athletes. 27 Black US college athletes had a considerably (about 3-5 times) higher risk of SCD compared with white athletes. 17, 27 The term 'black ethnicity' is ambiguous and comprises different populations such as Afro-American, Afro-Caribbean, Eastern-Africans and Western-Africans. Nuances within the term 'black ethnicity' as well as those denoting the term 'white (Caucasian) ethnicity' may have an important bearing on the incidence and cause of SCD. The issue of race is increasingly complicated as there are a growing number of individuals worldwide who are of mixed ethnicity (e.g. one white parent, one black parent).
Suggestion:
The demographic characteristics of an athlete should be documented. The issue of ethnicity is complex. In this regard the athletes should be categorized as Caucasian, or Black (African-American, Afro-Caribbean, Eastern-African, Western-African), or South American, or Asian (with specific information). In cases of mixed ethnicity data should include elaborate details of the origins of both parents.
Type of sport. Different sporting disciplines vary with respect to the magnitude of demand applied on the cardiovascular system, as illustrated in the frequently used Mitchell's classification of sports. 28 However, this classification does not completely define type of sports according to cardiac load, relative intensity of exertion, duration and haemodynamic and neuro-adrenergic load, factors that may be important for triggering SCA. In Bille's review of SCD in young athletes, the number of cases was highest in soccer, basketball and running. 29 Harmon et al. found the highest incidence in US collegiate basketball players (i.e. 1:11,000 per year). 17 A probable explanation of these differences is that various sporting disciplines have a dissimilar participation rate in different countries. Another point to be considered is the time spent in sport.
Suggestion: To include data on the type and characteristics of sport when the SCA occurred, whether SCA occurred during training or competition, as well as (estimated) number of years practising the sport. At present we recommend the use of the Mitchell's classification of sports. 28 Level of sport. The risk of SCA/SCD in competitive athletes seems increased compared with leisure sportsmen and non-athletes. 26 The incidence was 2.8 times higher in younger Italian competitive athletes compared with non-athletes. 30 In a US college athletes' material, the incidence of SCD was related to the increased level of competition; in division I 1:29,000, compared with division II (1:42,000) and division III (1:95,000). 17 Similarly, van Camp found a twofold increase in sudden death in college athletes compared with high school athletes. 31 Toresdahl et al. found a 3.6 times relative risk of SCA in high school student athletes compared with student non-athletes. 32 The relationships, however, between the level of sports and the risk of SCD are probably multi-factorial and complex and require further study.
The risk of a particular sport activity is also dependent on the type of athlete population engaged in that sport. For instance, marathon and cross-country competitions are mainly composed of amateur non-elite master athletes, and the incidence of SCD has been described to be 1-2/100,000. 2 Sahle´n et al. showed that certain participants in these races carry severe underlying cardiovascular disease. 33 The higher incidence figures reported in non-elite events, such as marathon, half marathons and recreational sports, 26 may be the expression of higherrisk population engaged in these sporting disciplines and not the type or level of sport activity per se.
Suggestion: In the SCA/SCD victim, define the precise level of the athletic activity, suggested as: elite level (professional and semi-professional)/competitive level (including usually more than 10 h exercise/week) recreational and leisure-time athletic activity and including the number of exercise hours/week.
Clinical information
A detailed personal and family history and knowledge of the precise circumstances of death are crucial items of information. Specifically, a known cardiac disease and the presence of antecedent symptoms (pre/syncope, chest pain, abnormal dyspnoea during activity), prior cardiac history, family history of premature (<50 years old) cardiac disease (coronary artery disease (CAD), cardiomyopathy, ablations or pacemaker implants and diabetes mellitus) are important elements for registration. In addition, availability of ECG recordings performed during life should be traced. Athletes with intellectual disabilities may carry a higher risk for defects of the heart and aorta.
Suggestion: Clinical data and all medical records prior to the event, including any available ECG, as well as other available diagnostic testing (echocardiography, cardiac magnetic resonance imaging (CMR), blood testing), should be registered. In addition, reports about the deceased athlete provided by relatives should be traced.
Aetiology of SCA/SCD in athletes
In young athletes, a wide spectrum of underlying inherited, congenital and acquired cardiovascular abnormalities are reported as a cause of SCD. 5, 23, 31, 34 The leading causes include diseases of the myocardium: cardiomyopathy (either hypertrophic cardiomyopathy (HCM) or arrhythmogenic right ventricular cardiomyopathy (ARVC)), coronary artery anomaly (CAA), premature coronary artery disease, cardiac ionchannelopathies (long and short QT-syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia), complications related to Marfan's syndrome, and acquired disorders; commotio cordis and acute myocarditis. [35] [36] [37] In master athletes, the primary cause of SCD is CAD. 2, 23, 38, 39 Regarding non-fatal SCA in athletes, there are no comprehensive data available. The knowledge of nonfatal causes of SCA relies on clinical evaluation of single cases and the extrapolation of the findings from cases of SCD.
Preparticipation evaluation affects the aetiology
Preparticipation evaluation of athletes may identify individuals harbouring diseases that may convey a greater risk of SCA in association to sports. According to the current recommendations, 40 affected athletes may be disqualified from competition or advised to restrict their athletic activity. Thus, the preparticipation evaluation procedure itself may affect the aetiology and incidence figures of SCD in a particular geographic region.
Pathology versus normal heart
The distinction between pathologic and normal variants is another challenge in the context of SCD in athletes. 41 Post-mortem diagnoses of HCM and ARVC are sometimes based on the presence of isolated, even mild, left ventricular hypertrophy (LVH), or fatty detection on the right ventricular wall, respectively, in the absence of the pathognomonic histological changes. 42 Isolated LVH, however, is a well-recognized feature of physiological cardiac adaptation to exercise. 43 Isolated fatty infiltration of the right ventricle may be present also in the normal heart. 44, 45 Moreover, uncertainty may exist as to the causal relationship between pathological findings and the SCD event. For instance, the significance of myxoid degeneration of the prolapsed mitral valve, stable atherosclerotic coronary plaque with limited (<50%) luminal stenosis, myocardial bridging, and focal myocarditis, may be overestimated and attributed as the cause of death. Such findings, however, are also relatively prevalent in the general population. 42 Therefore, caution should be used in interpreting the borderline pathologic findings, as suggested by the guidelines for autopsy investigation of SCD developed by the Association for European Cardiovascular Pathology. 41 Here the authors highlight the concepts of 'different degrees of certainty in defining the causeeffect relationship between the cardiovascular substrate and the sudden death event' and the existence of 'grey zones' particularly in the setting of myocardial diseases. 41 In these particular instances, screening of relatives may add information that clarifies the cause of death. Papadakis et al. demonstrated that familial evaluation of first-degree relatives of victims of SCD with post-mortem findings of uncertain causal effect could identify a primary arrhythmogenic syndrome in 46% of cases, a proportion similar to a contemporary series with normal post-mortem examinations (sudden arrhythmic death syndrome (SADS)). 42 
Post-mortem recommendations
The cause of SCD during sport should be established by autopsy, ideally by a cardiac pathologist, including histological evaluation of the ventricular myocardium, coronary arteries and specialized conduction tissue, or by additional genetic or toxicological tests. Identification of the cause of the SCD may be difficult in individual cases, due to the varied degree of morphologic expression of the arrhythmogenic cardiomyopathies, as well as the lack of structural abnormalities in purely electric syndromes. Difficulties in establishing the underlying cause greatly affects the precision of data of SCA/SCD in sports. In addition, many countries are not obliged to conduct autopsies. Therefore, the number of autopsies will be low, which will affect the precision and the understanding of the causes of SCD.
The results of the autopsy may trigger new specific screening efforts aimed at identifying potentially inherited cardiac pathology of first-degree relatives. 41 For example, the identification, or the absence, of any identifiable cardiac pathology at post-mortem directs the familial evaluation to a probable diagnosis of structural disorders or primary arrhythmic syndromes, respectively. Erroneous autopsy diagnoses may misguide familial evaluation or, conversely, offer false reassurance for surviving relatives and dissuade physicians from initiating familial screening altogether, with potentially devastating consequences for future generations. Thus, accurate interpretation of the autopsy findings by the pathologist is pivotal. 43, 44 According to the Association for European Cardiovascular Pathology Guidelines for autopsy investigation of SCD, full autopsy with sequential approach should always be performed to exclude extra-cardiac causes of sudden death, mostly cerebral or respiratory. 41 After exclusion of non-cardiac causes, any natural sudden death can be considered cardiac in origin. A detailed protocol of examination of the heart should be then applied to each case. Suggestion: Pathologists evaluating an athlete's heart should adhere to the guideline document produced by the Association for European Cardiovascular Pathology. The guidelines provide a detailed account on how to perform the post-mortem evaluation, interpret the results and assign the death to specific findings. Cases of SCD in sports in young individuals where diagnostic uncertainty persists (e.g. in all cases where the cause of death cannot be ascertained with certainty) should be referred for further evaluation to an expert cardiac pathologist. The examining pathologist should make a transverse apical section of the heart and take a small sample of myocardium, before fixing the full heart in formalin 10%. If the heart cannot be retained, it is essential that extensive photographic documentation is made and multiple samples of the myocardium are taken from a representative transverse slice of the ventricles to include the free wall of the left ventricle (anterior, lateral and posterior), the ventricular septum (anterior and posterior) and the free wall of the right ventricle (anterior, lateral and posterior), as well as right ventricular outflow tract and one block from each atrium. Furthermore, any segment of the myocardium, coronary arteries, valves and great vessels with significant macroscopic abnormalities should be sampled for histology and stained with haematoxylin and trichrome. Additional stains are performed as indicated. For molecular and toxicological studies, appropriate storage of autopsy tissues and fluids is essential. If no on-site facilities are available, the stored material should be sent to the nearest specialized laboratory.
The autopsy report should include a detailed description relating to the histopathological evidence that supports the final diagnosis and the degree of certainty of a cause-effect relationship between the identified substrate and the SCD (i.e. certain, highly probable or uncertain cause of SCD). 41, 42 It is recommended that EDTA blood (10 ml) is frozen at À20 C and heart and spleen tissues (5 g) are either frozen and stored at À80 C, or stored in RNA later at 4 C for up to two weeks before extraction. 41 Samples can be utilized to look for viral DNA-RNA genomes by PCR and reverse transcription polymerase chain reaction (RT-PCR), as well as genetic screening by DNA direct sequencing in suspected genetically determined heart diseases (molecular autopsy).
Evaluation of relatives. Evaluation of first degree relatives with ECG or an exercise stress test may provide answers to the cause of death in autopsy-negative cases. In such instances, molecular testing of an arrhythmia syndrome related gene panel can be useful for making a diagnosis and if targeted to genes relevant to the findings in a family may support the underlying diagnosis. 46 
Molecular autopsy
When performing an autopsy of a SCD case, in which the heart is morphologically 'normal' and no other aetiology, on toxicology or otherwise, can be identified, the death is labelled as SADS. 47, 48 Molecular autopsy and familial studies in victims of SADS indicate that a considerable proportion of deaths may be attributed to primary arrhythmogenic cardiac disease. Therefore, we believe it to be appropriate that all cases of sudden death in athletes that remain unexplained despite autopsy by an experienced pathologist should undergo genetic analysis for the most common arrhythmogenic syndromes. This may provide a diagnostic result in an additional 20-30% of cases, and may be applied for cascade genetic testing in relatives. If the genetic result is negative, clinical screening should still be advised for first-degree relatives. In this setting, cardio genetic family screening may represent a good opportunity to achieve a diagnosis of the 'culprit' inherited heart disease and to identify other relatives at risk. 46, 49 
Virtual autopsy
Virtual autopsy through comprehensive postmortem imaging is evolving and has been proposed as an alternative to traditional autopsy, particularly in the forensic setting. 50, 51 Taking into account the most common causes and mechanism of SCD in athletes, however, it could assist in the few mechanical SCDs (i.e. pulmonary embolism, haemopericardium), but would fail to detect the majority of SCDs due to electrical abnormalities. However, virtual autopsy may prove invaluable in excluding extra-cardiac causes of death in athletes when autopsy is denied by relatives either due to personal or cultural reasons. Thus, modern imaging techniques provide an opportunity for post-mortem diagnostics to complement, but not replace, traditional autopsy, when looking for the wide spectrum of causes of SCD in competitive athletes.
Toxicology
Despite the large number of circumstantial reports, there is no clear scientific and unequivocal evidence supporting or invalidating the wide perception of the influence of doping on SCA/SCD in sports. Only registration of toxicological agents over time would help to clarify the actual role of doping in SCA/SCD. Indirect evidence, however, links the abuse of illicit drugs to SCA in sports. Such drugs may trigger a wide range of exercise-related cardiac arrhythmias that can be lethal. 52 Abuse of performanceenhancing substances is associated with LVH and repolarization changes. 53 A body of information exists on cardiovascular side effects of anabolic steroids (AASs), including lipoprotein profile abnormalities, thrombotic diathesis, coronary vasoconstriction, cardiac arrhythmias and increase of blood pressure. 54, 55 Case studies point to AAS abuse being linked to acute myocardial infarction and fatal ventricular arrhythmias. 56 Other substances have also been associated with sudden death in sport such as stimulants (amphetamines, cocaine, ephedrine alkaloids) and erytropoietin (EPO). 52, [56] [57] [58] Since there is a large inter-individual variability in responses to a drug, the adverse effects depend on the type, amount and duration of intake of the consumed drug as well as the individual susceptibility. 55 Scientific reports describing the cardiovascular deleterious effects of drug abuse are scarce. Therefore, even when the heart is found to be abnormal during macroscopic and microscopic examination, toxicology screen for illicit substances should always be performed prior to attributing the findings to a primary cardiomyopathy.
Suggestion: When investigating SCA/SCD in sports, we recommend full screening of toxic and possible doping substances and referral of urine and blood samples to the closest qualified laboratory. In the case of doping substances, follow the legal procedures to allow the testing to be performed. A proper selection, collection and submission of specimens for toxicological analyses are mandatory for accurate and scientifically valid results. Athlete's samples as urine, blood or other matrix, including DNA or genomic profiling for any legitimate anti-doping purpose can be used. 59 The target, and the challenge, is to obtain accurate and sensitive assessment of used substances in urine or blood in due time after their intake. 55 Toxicological analyses should be quantitative and the following amounts are usually required: heart blood 25 ml, peripheral blood from femoral veins 10 ml, urine 30-50 ml and bile 20-30 ml (when urine is not available). All samples are stored at 4 C. A lock of hair (100-200 mg) for possible chronic drug abuse testing should be cut from the back head or from the pubic hair.
Limitations of autopsy
A common perception is that autopsy presents the definitive causal answer to the death. Whilst it may provide the most definitive answer in several cases, it is imperfect. The reproducibility of autopsy diagnoses is scarcely studied. Therefore, we reasonably assume that variance in the autopsy reports describing aetiology of SCD in sports may also be related to the variability of the procedures in postmortem assessments. Additionally, diagnosis may be difficult in the case of borderline pathologic features, such as mild LVH or ventricular dilation, or when the significance of the pathologic report is controversial, such as in the case of isolated myocardial bridging, mild right ventricular fatty infiltration, scattered inflammatory cells or isolated spots of fibrosis.
Other potential limitations of the autopsy are related to the quality of assessment by the forensic pathologist who performs the initial examination in most cases of sudden death. This is underscored by the fact that SCDs in athletes are caused by a spectrum of different conditions whose prevalence in the general population is low. Consequently, the performing forensic pathologist may have limited experience with the diagnoses of conditions predisposing to SCD in athletes. It has been shown that a large disparity exists as to the potential cause of death when comparing specialized cardiac pathologist versus general pathologist reports. 60 General pathologists are more likely to attribute death to structural causes rather than designate the heart as normal, by attributing, for instance, isolated fatty infiltration of the right ventricle to ARVC and LVH, in the absence of myocyte disarray, to HCM.
Diagnoses based on circumstantial evidence
Some diagnoses are based on circumstantial evidence particularly when the autopsy fails to identify an underlying cardiac abnormality. Commotio cordis is the result of a malignant ventricular arrhythmia caused by a sudden, blunt trauma to the chest. 61 Commotio cordis was the cause of SCD in 20% of cases reported by Maron, 62 but is probably underreported in Europe. 63 Baseball is the leading cause in the USA, but commotio cordis has also been reported in soccer, ice-hockey and karate. 61 The diagnosis of commotio cordis is dependent on a thorough description of the circumstances related to the event preceding collapse of the athlete.
Suggestion: Describe precisely the circumstances (including any collision between the victim and another person or an object like a ball) related to the SCA/SCD in sport.
Management of SCA
Infrastructure on the sport site Sport can be practised in various locations, at sports fields, but also in cities or in isolated and remote areas. Information concerning the infrastructure at a specific site where SCA/SCD has occurred should be recorded. This may include the management of the SCA, the skills available to deal with SCA (cardiopulmonary resuscitation (CPR)), the availability of cardiac defibrillation equipment and the speed at which the appropriate interventions were delivered. Teams, clubs, schools and other establishments organizing sports are in a unique position to monitor their athletes for cases of SCA/SCD, and subsequently to report incidents through a uniform registration protocol. As emergency procedures in sporting venues greatly impact outcomes from SCA, every organization should have in place an acute cardiovascular emergency procedure to respond to a collapsed athlete. 64 A comprehensive emergency response plan for SCA, including rapid public access to an automated external defibrillator (AED), increases the likelihood of bystander CPR, reduces the time to defibrillation and improves survival from SCA in the athletic setting. 65, 66 Successful emergency response plan programmes require an organized and practised response, an established communication method to activate the local emergency medical services system, and rescuers trained and equipped to provide CPR and defibrillation.
Borjesson et al. surveyed the emergency cardiovascular care at major sporting arenas in Europe, questioning the emergency planning, availability of AEDs, emergency personnel and distance to the nearest hospital. Only 64% of major football arenas had a written medical action plan for SCA, and 72% had on-site AEDs. In addition, approximately 25% of the arenas situated longer than 10 minutes from the nearest hospital did not have an on-site AED. 67 These findings led to the development of European consensus recommendations on cardiovascular safety at sports arenas. 68 Suggestion: Include data both of the site of the SCA and of the cardiovascular preparedness (medical action plan, presence of AED and training of rescuers) of the sporting site in the registry.
Resuscitation
The success of out-of-hospital resuscitation depends on early recognition of the situation, willingness and knowledge on how to perform CPR, or how to apply an AED. Data indicate that increased public awareness of SCA/SCD in sports may have improved survival rate after SCA. 7, 8 Delayed recognition of SCA by first responders can lead to delays or even failure to activate the emergency response system, initiate CPR and provide early defibrillation. Resuscitation may be delayed for several reasons; people are reluctant to resuscitate, or SCA is mistaken for a seizure or other cause of collapse. 65 Another challenge in recognizing SCA in athletes includes inaccurate rescuer-assessment of pulse or respiration. 69 Unfortunately, bystander CPR is initiated in less than one-third of cases of witnessed SCA in the general population 69 and, if initiated, more than 40% of chest compressions are of insufficient quality. 70 Consensus guidelines and several public access defibrillation studies uniformly support access to early defibrillation, targeting a time interval of less than 3-5 min from collapse to first shock. 64, 71 Reports from schools with an on-site AED programme sustain an improved survival rate for young athletes with SCA if early defibrillation is achieved. 65, 66 Rapid defibrillation has led to increase in survival rates if bystander CPR is provided and defibrillation occurs rapidly, 2, 72 although the underlying disease also is an important factor. 12 There is a great variation in the use of bystander CPR 73 also, within the same country. 74, 75 It is prudent to get detailed and uniform information about resuscitation procedures in cases of SCA, to improve the management of these events.
Suggestion: Use the form in Appendix 1, adapted from the Utstein criteria, 76, 77 to obtain uniform data on clinical management of SCA/SCD in athletes. Data on delay of action, CPR, defibrillation time and history as well as advanced life support should be included.
Framework for a registry
An accurate registry of SCA/SCD is dependent on an organizational frame collecting systematic information from various collaborative sources including emergency services, witnesses, hospitals, pathologists and toxicologists. Collaboration among the different actors in the scenario of a sudden death in sports is illustrated by experience derived from the registry from the Veneto region of Italy 1 and from registries in Switzerland and the Netherlands. 78, 79 Suggestions: Scientific and sporting organizations should promote a national registry which national public health authorities should undertake and maintain the responsibility of. Mandating the reporting system may be an obstacle. To integrate sports-related SCA/ SCD in existing death certificate system or other registration system might be a future aim.
As a start, we suggest that at the very least SCA/SCD among competitive athletes in organized sports should be included. Individual countries may choose to also include recreational athletes based on feasibility of their infrastructure. The inclusion of all individuals suffering a SCA/SCD during exercise, though, is desirable to provide a comprehensive understanding of the issue.
The creation of a national body responsible for the collection of the data on SCA would be ideal. Similarly, it would be prudent to establish a working group on SCD including genetic counselling of first degree relatives. In the instances where an athlete is considered to have died from a potentially inherited condition, it would be prudent to approach first degree relatives and discuss inherited disease and prompt referral to a cardiac expert in the field. A good network and co-operation with relevant national institutes of forensic medicine is essential for the functioning of the registries.
If a registry website is established, it should include access both for professionals and for observers like relatives, coaches and journalists. The aim is to complete information, which later must be quality-tested.
In cases of SCA, the need for professional help for the bereaved must be acknowledged.
If health personnel are time constrained due to extraordinary circumstances when completing the registration form, as a minimum, the identity of the victim and date of the event must be filled in, thus completing the lower quality of data necessary.
To uphold the necessary motivation of the people to submit all cases continuously is a challenge and should be encouraged repeatedly. This necessitates continued education and information to the relevant health care providers. Research from the registries will aid in continuous education and in spreading the information.
Concluding remarks
There is a pressing need for uniform registration of sport-related SCA/SCD in order to improve our understanding of these tragedies. The aim of this document is to provide a comprehensive outline for such a registry that would be applicable in different countries despite potential practical, ethical and medico-legal challenges. It is our aspiration that national organizations and public health authorities may look favourably upon these recommendations as they are or refine them in the future, as a model on how to construct national registries on SCA/SCD in sports and to design future epidemiological studies.
